Doravirine Use in Treatment-Experienced HIV-Positive Patients

被引：7
|
作者：
Fulco, Patricia Pecora [1 ]
Herity, Leah B. [1 ]
机构：
[1] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA
来源：
ANNALS OF PHARMACOTHERAPY | 2021年 / 55卷 / 01期
关键词：
D O I：
10.1177/1060028020935763
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：127 / 130
页数：4
相关论文
共 50 条
  • [1] Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients
    Calcagno, A.
    Marinaro, L.
    Nozza, S.
    Aldieri, C.
    Carbone, A.
    Ghisetti, V.
    Trentalange, A.
    D'Avolio, A.
    Castagna, A.
    Di Perri, G.
    Bonora, S.
    ANTIVIRAL RESEARCH, 2014, 108 : 44 - 47
  • [2] Successful use of the potent enzyme inducer enzalutamide in a treatment-experienced HIV-positive male with prostate cancer
    Nhean, Salin
    Bravo, Jam
    Sheehan, Nancy L.
    Walmsley, Sharon
    Tilley, David
    Tseng, Alice L.
    AIDS, 2018, 32 (17) : 2640 - 2642
  • [3] Real-life use of Doravirine in treatment-experienced people living with HIV: A multicenter Italian study
    Mazzitelli, Maria
    Degli Antoni, Melania
    Castelli, Francesco
    Ripamonti, Diego
    Zuglian, Gianluca
    Lapadula, Giuseppe
    Fabbiani, Massimiliano
    Ferraresi, Alice
    Putaggio, Cristina
    Cattelan, Anna Maria
    Quiros-Roldan, Eugenia
    MEDICINE, 2022, 101 (30) : E29855
  • [4] Etravirine use evaluation in the management of HIV treatment-experienced patients
    Margusino, L.
    Vazquez, P.
    Lopez, S.
    Castro, A.
    Pertega, S.
    Martin, I.
    Pazos, L. Elberdin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 452 - 453
  • [5] Short-Term Clinical Outcomes Among Treatment-Experienced HIV-Positive Patients with Early Low Level Viremia
    Chao, Chun
    Tang, Beth
    Towner, William
    Silverberg, Michael J.
    Hurley, Leo
    Horberg, Michael
    AIDS PATIENT CARE AND STDS, 2012, 26 (05) : 253 - 255
  • [6] Impact of body changes on the quality of life of HIV-positive treatment-experienced patients - an online community-based survey
    Vergel, N.
    ANTIVIRAL THERAPY, 2008, 13 (08) : A85 - A85
  • [7] Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study
    De La Mata, Nicole L.
    Cooper, David A.
    Russell, Darren
    Smith, Don
    Woolley, Ian
    Sullivan, Maree O.
    Wright, Stephen
    Law, Matthew
    SEXUAL HEALTH, 2016, 13 (04) : 335 - 344
  • [8] Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre
    Borghetti, Alberto
    Mondi, Annalisa
    Piccoli, Benedetta
    Gagliardini, Roberta
    Lamonica, Silvia
    Ciccarelli, Nicoletta
    D'Avino, Alessandro
    Pallavicini, Federico
    Cauda, Roberto
    De Luca, Andrea
    Fabbiani, Massimiliano
    Di Giambenedetto, Simona
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 198 - 199
  • [9] Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression
    Smith, C. J.
    Phillips, A. N.
    Dauer, B.
    Johnson, M. A.
    Lampe, F. C.
    Youle, M. S.
    Tyrer, M.
    Staszewski, S.
    HIV MEDICINE, 2009, 10 (01) : 19 - 27
  • [10] Raltegravir A Review of its Use in the Management of HIV Infection in Treatment-Experienced Patients
    Croxtall, Jamie D.
    Keam, Susan J.
    DRUGS, 2009, 69 (08) : 1059 - 1075
12345